These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7191487)

  • 1. Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.
    Slater P; Crossman AR
    Neuropharmacology; 1980 Mar; 19(3):289-95. PubMed ID: 7191487
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of narcotic analgesics on the turning behaviour of rats with 6-hydroxydopamine-induced unilateral nigro-striatal lesions.
    Slater P; Blundell C; Crossman AR
    Neuropharmacology; 1980 Feb; 19(2):187-93. PubMed ID: 6102357
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway.
    Reavill C; Leigh N; Jenner P; Marsden CD
    Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA.
    Hefti F; Melamed E; Sahakian BJ; Wurtman RJ
    Pharmacol Biochem Behav; 1980 Feb; 12(2):185-8. PubMed ID: 7189592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
    Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
    Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 8. The importance of calcium in amphetamine-induced turning behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    Neuropharmacology; 1980 Jun; 19(6):555-60. PubMed ID: 6772983
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of morphine on circling behaviour in rats with 6-hydroxydopamine striatal lesions and electrolesions of the raphe nucleus.
    Slater P
    Pharmacol Biochem Behav; 1981 May; 14(5):625-30. PubMed ID: 7195577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal A2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation.
    Brown SJ; Gill R; Evenden JL; Iversen SD; Richardson PJ
    Psychopharmacology (Berl); 1991; 103(1):78-82. PubMed ID: 1900945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome.
    Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):37-40. PubMed ID: 772721
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract]   [Full Text] [Related]  

  • 17. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
    Price MT; Fibiger HC
    Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
    [No Abstract]   [Full Text] [Related]  

  • 18. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
    Costall B; Naylor RJ; Pycock C
    J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of ethanol on turnover and function of striatal dopamine.
    Lai H; Makous WL; Horita A; Leung H
    Psychopharmacology (Berl); 1979 Mar; 61(1):1-9. PubMed ID: 108711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurological basis of motor asymmetry following unilateral nigrostriatal lesions in the rat: the effect of secondary superior colliculus lesions.
    Crossman AR; Sambrook MA
    Brain Res; 1978 Dec; 159(1):211-3. PubMed ID: 569529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.